Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bifidobacterium Lactis
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Medical University of Lublin
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 01, 2021
Lead Product(s) : Bifidobacterium Lactis
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Medical University of Lublin
Deal Size : Inapplicable
Deal Type : Inapplicable